Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

WIMMlogo-justsquare

Doug Higgs (WIMM) and Peter Donnelly (WTCHG) have been awarded a collaborative Wellcome Trust Strategic grant (~£3M) to develop a systematic approach to understanding the biology underpinning GWAS hits.  Our aim is to establish a pipeline for identifying causative SNPs and the genes they regulate.  Initially we will study red cell traits (with David Roberts and Dominic Kwiatowski), type 2 diabetes (with Mark McCarthy and Anna Gloyn) and multiple sclerosis (with Lars Fugger and Calli Dendrou).  The pipelines for analysing RNA expression, chromatin modifications,  and chromosme conformation capture will be developed by Doug Higgs, Anna Gloyn and Jim Hughes and we intend that these will ultimately be generally available to others studying human genetic and epigenetic diseases in the WIMM.  Tudor Fulga and Tatjana Sauka Spengler will help develop the tools for genome editing of primary cells and iPS lines (from Zam Cader).  High end statistical genetics and computational biology will be undertaken by Peter Donnelly and Gil McVean.  Hopefully this will be an exciting new venture for the WIMM.

Similar stories

T cell Immunotherapy animation launched

A new animation explores work by the Chakraverty Group, Vyas Group, and Professor Borrow from the Jenner Institute.

Irene Roberts delivers Ham-Wasserman Lecture

Presented at the American Society of Hematology Annual Meeting, the award and lectureship recognises individuals from outside the United States who have made significant contributions to Haematology.

Asger Jakobsen receives ASH-BSH Abstract Achievement Award

Dr Jakobsen, a Clinical Research Fellow and DPhil student from the Vyas Group has received the award from the American Society of Hematology and the British Society of Haematology.

Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing

The biotechnology company builds upon research conducted by Professor Jim Hughes and Prof. James Davies at the MRC Weatherall Institute of Molecular Medicine, and combines 3D genome technology and machine learning to decode the dark matter of the human genome.

KJ Patel appointed new Chief Scientist of CRUK

Alongside his new role at Cancer Research UK, Prof. Patel will continue as the Director of both the MRC Weatherall Institute for Molecular Medicine (MRC WIMM) and the MRC Molecular Haematology Unit (MRC MHU).